Manus Bio Overview
- Founded
- 2011

- Status
- Private
- Employees
- 90

- Latest Deal Type
- Series B
- Latest Deal Amount
- $75M

- Investors
- 14
Manus Bio General Information
Description
Developer of an advanced fermentation technology designed to recreate plant processes in microorganisms to produce natural ingredients through fermentation. The company's technology helps in manufacturing complex and bioactive natural products such as flavors, fragrances, food ingredients, bio-pesticides and pharmaceuticals, enabling users to access these natural ingredients across the world.
Contact Information
- 1030 Massachusetts Avenue
- Suite 300
- Cambridge, MA 02138
- United States
Manus Bio Timeline
Manus Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC (Series B) | 06-Nov-2020 | $75M | 000.00 | 00000 | Completed | Generating Revenue |
12. Debt - PPP | 15-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
11. Later Stage VC (Series A1) | 05-Jun-2018 | 00.00 | 000.00 | 0000 | Completed | Generating Revenue |
10. Grant | 11-Jan-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
9. Grant | 01-Jan-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
8. Grant | 01-Jan-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
7. Later Stage VC (Series A) | 29-Dec-2017 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
6. Seed Round | 06-Oct-2016 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
5. Grant | 01-Jul-2016 | $225K | $667K | Completed | Generating Revenue | |
4. Accelerator/Incubator | $667K | Completed | Generating Revenue |
Manus Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B3 | 000,000 | 00.000000 | 00 | 000.0 | 000.0 | 00 | 000.0 | 0.000 |
Series B2 | 00,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series B1 | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Series A1 | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Series A | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Seed 2 | 616,765 | $0.001000 | 5% | $4.86 | $4.86 | 1x | $4.86 | 10.56% |
Seed 1 | 88,951 | $0.001000 | 10% | $4.6 | $4.6 | 1x | $4.6 | 1.52% |
Manus Bio Comparisons
Industry
00000
000 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialManus Bio Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Lygos | Venture Capital-Backed | Berkeley, CA | 00 | 000.00 | 000000000 - | 000.00 |
000 00000000000000 | Venture Capital-Backed | Boulder, CO | 00 | 000.00 | 0000000000 0 | 000.00 |
000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
00000000000 000000 | Venture Capital-Backed | Vancouver, Canada | 00 | 000.00 | 000000000000 | 000.00 |
0000000 | Corporation | Bedford, MA | 000 | 000000000 - |
Manus Bio Executive Team (8)
Manus Bio Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Ajikumar Parayil Ph.D | Self | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |
Byron Alsberg | Prefix Capital | Board Member | 000 0000 |
Colin Gounden | Self | Board Member | 000 0000 |
Gregory Stephanopoulos Ph.D | Manus Bio | Co-Founder & Board Member | 000 0000 |
Kittiphong Limsuwannarot | BBGI | Board Member | 000 0000 |
Manus Bio Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialManus Bio Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BBGI | Corporation | Minority | 000 0000 | 000000 0 | |
Liebenthal Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Prefix Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
EGI Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Taihill Venture | Venture Capital | Minority | 000 0000 | 000000 0 |
Manus Bio Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 00000000000 | 17-Nov-2020 | 00000 0000000 | Food Products | 00000000 0000000 00.0 | |
NutraSweet (Plant in Augusta, Georgia) | 29-Jun-2018 | Corporate Asset Purchase | Buildings and Property | 00000000 0000000 00.0 |